G1 Therapeutics to discontinue cancer drug trial

G1 Therapeutics

13/02/2023 11:24

(Repeats with no changes to text)
       Feb 13 (Reuters) - G1 Therapeutics Inc  GTHX.O  on
Monday said it would terminate its cancer therapy trial as the
placebo outperformed the drug in the late-stage trial. 
 (Reporting by Sriparna Roy in Bengaluru; Editing by Dhanya Ann
Thoppil)
 ((Sriparna.Roy@thomsonreuters.com;))